A phase I open-label dose-escalation study of oral BIBF 1120 combined with standard paclitaxel and carboplatin in patients with advanced gynecological malignancies (Q35011280)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase I open-label dose-escalation study of oral BIBF 1120 combined with standard paclitaxel and carboplatin in patients with advanced gynecological malignancies |
scientific article |
Statements
1 reference
A phase I open-label dose-escalation study of oral BIBF 1120 combined with standard paclitaxel and carboplatin in patients with advanced gynecological malignancies (English)
1 reference
S Loibl
1 reference
A du Bois
1 reference
J Huober
1 reference
P Stopfer
1 reference
J Pfisterer
1 reference
P Wimberger
1 reference
V L Reichardt
1 reference
P Harter
1 reference
4 November 2009
1 reference
1 reference
21
1 reference
2
1 reference
370-375
1 reference
Identifiers
1 reference
1 reference